Literature DB >> 16714295

Ataxin-10 interacts with O-linked beta-N-acetylglucosamine transferase in the brain.

Pia März1, Jörg Stetefeld, Kerstin Bendfeldt, Cordula Nitsch, Jochen Reinstein, Robert L Shoeman, Beatrice Dimitriades-Schmutz, Martine Schwager, Dominic Leiser, Sabire Ozcan, Uwe Otten, Suat Ozbek.   

Abstract

Modification by O-GlcNAc involves a growing number of eucaryotic nuclear and cytosolic proteins. Glycosylation of intracellular proteins is a dynamic process that in several cases competes with and acts as a reciprocal modification system to phosphorylation. O-Linked beta-N-acetylglucosamine transferase (OGT) levels are highest in the brain, and neurodegenerative disorders such as Alzheimer disease have been shown to involve abnormally phosphorylated key proteins, probably as a result of hypoglycosylation. Here, we show that the neurodegenerative disease protein ataxin-10 (Atx-10) is associated with cytoplasmic OGT p110 in the brain. In PC12 cells and pancreas, this association is competed by the shorter OGT p78 splice form, which is down-regulated in brain. Overexpression of Atx-10 in PC12 cells resulted in the reconstitution of the Atx-10-OGT p110 complex and enhanced intracellular glycosylation activity. Moreover, in an in vitro enzyme assay using PC12 cell extracts, Atx-10 increased OGT activity 2-fold. These data indicate that Atx-10 might be essential for the maintenance of a critical intracellular glycosylation level and homeostasis in the brain.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16714295     DOI: 10.1074/jbc.M601563200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

Review 1.  The intersections between O-GlcNAcylation and phosphorylation: implications for multiple signaling pathways.

Authors:  Quira Zeidan; Gerald W Hart
Journal:  J Cell Sci       Date:  2010-01-01       Impact factor: 5.285

Review 2.  The making of a sweet modification: structure and function of O-GlcNAc transferase.

Authors:  John Janetzko; Suzanne Walker
Journal:  J Biol Chem       Date:  2014-10-21       Impact factor: 5.157

Review 3.  Critical observations that shaped our understanding of the function(s) of intracellular glycosylation (O-GlcNAc).

Authors:  Natasha E Zachara
Journal:  FEBS Lett       Date:  2018-11-24       Impact factor: 4.124

Review 4.  O-GlcNAc and the epigenetic regulation of gene expression.

Authors:  Brian A Lewis; John A Hanover
Journal:  J Biol Chem       Date:  2014-10-21       Impact factor: 5.157

Review 5.  Nutrient-driven O-GlcNAc in proteostasis and neurodegeneration.

Authors:  Ilhan Akan; Stephanie Olivier-Van Stichelen; Michelle R Bond; John A Hanover
Journal:  J Neurochem       Date:  2017-11-20       Impact factor: 5.372

Review 6.  O-GlcNAc cycling: implications for neurodegenerative disorders.

Authors:  Brooke D Lazarus; Dona C Love; John A Hanover
Journal:  Int J Biochem Cell Biol       Date:  2009-03-27       Impact factor: 5.085

Review 7.  O-GlcNAc transferase and O-GlcNAcase: achieving target substrate specificity.

Authors:  Alexis K Nagel; Lauren E Ball
Journal:  Amino Acids       Date:  2014-08-31       Impact factor: 3.520

Review 8.  The hexosamine signaling pathway: O-GlcNAc cycling in feast or famine.

Authors:  John A Hanover; Michael W Krause; Dona C Love
Journal:  Biochim Biophys Acta       Date:  2009-07-30

9.  O-linked beta-N-acetylglucosaminyltransferase substrate specificity is regulated by myosin phosphatase targeting and other interacting proteins.

Authors:  Win D Cheung; Kaoru Sakabe; Michael P Housley; Wagner B Dias; Gerald W Hart
Journal:  J Biol Chem       Date:  2008-10-07       Impact factor: 5.157

Review 10.  Protein truncation as a common denominator of human neurodegenerative foldopathies.

Authors:  Santosh Jadhav; Norbert Zilka; Michal Novak
Journal:  Mol Neurobiol       Date:  2013-03-21       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.